(Q37708614)

22 August 2017

1 reference

title

Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension (English)

1 reference

22 August 2017

main subject

arterial hypertension

0 references

author name string

Peter M Rothwell

series ordinal

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

375

1 reference

22 August 2017

issue

9718

1 reference

22 August 2017

page(s)

938-948

1 reference

Global burden of blood-pressure-related disease, 2001.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure variability causes spurious identification of hypertension in clinical studies: a computer simulation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

When measurements are misleading: modelling the effects of blood pressure misclassification in the English population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Serial Changes in Blood Pressure from Adolescence into Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Systolic hypertension in the elderly. An epidemiologic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Variability of blood pressure and the results of screening in the hypertension detection and follow-up program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Twenty-four-hour ambulatory blood pressure profiles of high-risk patients in general practice: data from an ambulatory blood pressure monitoring registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prognostic influence of office and ambulatory blood pressures in resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Ambulatory blood-pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Relationships among blood pressures obtained using different measurement methods in the general population of Ohasama, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Hypertension control: how well are we doing?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Treatment of hypertension in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Clinical implication of morning blood pressure surge in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Triggering risk factors for ischemic stroke: a case-crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

The cardiovascular toll of stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Orthostatic hypertension: a measure of blood pressure variation for predicting cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Orthostatic hypertension: when pressor reflexes overcompensate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Personality characteristics influencing determinacy of day and night blood pressure and heart rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Trait hostility and ambulatory blood pressure among traffic enforcement agents: the effects of stressful social interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Intra-individual postural blood pressure variability and stroke in elderly nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Long-term risk of sustained hypertension in white-coat or masked hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Masked hypertension: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Change in blood pressure and incident dementia: a 32-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Ethnic Group Disparities in 10-Year Trends in Stroke Incidence and Vascular Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Beta-blockers for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effect of different antihypertensive drug classes on central aortic pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Long-term effects of statins on arterial pressure and stiffness of hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Regional cerebral autoregulation during orthostatic stress: age-related differences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Cerebral hemodynamics after short- and long-term reduction in blood pressure in mild and moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Autoregulation of brain circulation in severe arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960309-1

7 January 2021

10.1016/S0140-6736(10)60309-1

Identifiers

DOI

1 reference

22 August 2017

1 reference